First Edition: March 27, 2024
March 27, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Programas de inteligencia artificial diagnostican retinopatía diabética en minutos
By Hannah Norman
March 27, 2024
KFF Health News Original
En medio de todo el revuelo en torno a la inteligencia artificial en la atención médica, la tecnología de exámenes de la vista está surgiendo como uno de los primeros casos de uso probados de diagnósticos basados en IA en un entorno clínico.
The Burden of Getting Medical Care Can Exhaust Older Patients
By Judith Graham
March 27, 2024
KFF Health News Original
It’s estimated that an older patient can spend three weeks of the year getting care — and that doesn’t count the time it takes to arrange appointments or deal with insurance companies.
Some Medicaid Providers Borrow or Go Into Debt Amid ‘Unwinding’ Payment Disruptions
By Katheryn Houghton
March 27, 2024
KFF Health News Original
Used to operating with scarce resources, Montana Medicaid providers say gaps in state payments have left them struggling further.
As AI Eye Exams Prove Their Worth, Lessons for Future Tech Emerge
By Hannah Norman
March 27, 2024
KFF Health News Original
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
Listen to the Latest ‘KFF Health News Minute’
March 26, 2024
KFF Health News Original
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
This State Isn’t Waiting for Biden To Negotiate Drug Prices
By Elisabeth Rosenthal
March 26, 2024
KFF Health News Original
As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an “upper payment limit” for drugs it deems unaffordable. In late […]
Viewpoints: Weight-Loss Drugs Don’t Help Everyone; We Mustn’t Let Anti-Vax Beliefs Become Normalized
March 26, 2024
Morning Briefing
Editorial writers discuss weight-loss drugs, vaccine misinformation, and reproductive health care.
Bird Flu Detected In Some Dairy Cows In US
March 26, 2024
Morning Briefing
The Department of Agriculture said Monday that the milk supply is safe due to pasteurization, after samples collected from sick cattle in Kansas and Texas tested positive for the avian influenza virus.
DeSantis Signs Into Law A Social Media Ban For Kids Under 14
March 26, 2024
Morning Briefing
The law also requires parental permission for 14- and 15-year-olds to set up accounts on social media platforms like Instagram and TikTok. It is scheduled to take effect on Jan. 1, 2025 and is expected to be challenged in court in the interim.
Study: Insulin Price Caps Alone Are Not Enough To Improve Access
March 26, 2024
Morning Briefing
Other research-related news is on brain health risks from common household chemicals, gender- and race-based disparities in heart transplants, a new blood test to detect colon cancer, and more.
States Crack Down On Facility Fees As Part Of Hospital Pricing Push
March 26, 2024
Morning Briefing
Modern Healthcare reports that states are tackling high hospital prices by restricting facility fees, despite a “lag” in federal-level policy. Meanwhile, labor shortages and other pressures could force more providers to shed personal care services.
Scientists Warn Of Brain Health Risk From Reused Deep-Frying Oil
March 26, 2024
Morning Briefing
Also in the news, a vast archive of ancient brains is in the spotlight for how it may help our modern understanding of mental illness. Scientists also uncover why women are more easily addicted to cigarettes than men.
Colorado Price Cap On Arthritis Drug Enbrel Targeted By Amgen Lawsuit
March 26, 2024
Morning Briefing
The multinational pharma company is suing Colorado over the state prescription drug board’s plan to cap the price of its blockbuster drug. Also in the news: New Hampshire’s troubled ambulance market; naloxone in Florida; and more.
Morning Briefing for Tuesday, March 26, 2024
March 26, 2024
Morning Briefing
Mifepristone Supreme Court case, cancer treatment, bird flu, social media, insulin price caps, facility fees, and more are in the news.
Future Of Abortion Pill Under Threat As Supreme Court Trial Opens
March 26, 2024
Morning Briefing
The Supreme Court will hear arguments today in a case that challenges access mifepristone, one of two drugs used in a medication abortion. News outlets cover what’s at stake for the FDA and drug industry, how abortion could be further limited, and claims that distorted science is playing a role.
First Edition: March 26, 2024
March 26, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Year
By Arthur Allen
March 26, 2024
KFF Health News Original
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
At Stake in Mifepristone Case: Abortion, FDA’s Authority, and Return to 1873 Obscenity Law
By Sarah Varney
March 25, 2024
KFF Health News Original
The end goal for a conservative Christian group’s mifepristone case before the Supreme Court: a de facto nationwide abortion ban.